Biotech News
Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
investors.designtx.com2026-05-06 14:59 EST
CARLSBAD, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2025 Cantor Global